The prevalence of Microsporidium among patients given a diagnosis of cancer

Basit Öğe Kaydı
dc.authorscopusid13611422300
dc.authorscopusid22978273500
dc.authorscopusid22979099500
dc.authorscopusid11738942300
dc.contributor.authorKaraman U.
dc.contributor.authorAtambay M.
dc.contributor.authorDaldal N.
dc.contributor.authorColak C.
dc.date.accessioned2024-08-04T20:01:06Z
dc.date.available2024-08-04T20:01:06Z
dc.date.issued2008
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe aim of this study was to determine the frequency of Microsporidium among patients given a diagnosis of cancer. For this purpose fecal samples from 320 patients aged 23.60+/-23.00 years were examined using native-Lugol and sedimentation methods and evaluated with modified trichrome, trichrome, and calcofluor dyes. Moreover a control group of 320 non-cancer patients was set up. While 10.9% of the patient group was found to have Microsporidium, only 5.6% of the control group did. Comparison between the control and patient groups in terms of presence of Microsporidium revealed a statistically significant difference. The analysis of a possible relation between intestinal parasites and the presence of Microsporidium revealed a statistically significant correlation between Microsporidium and Blastocystis hominis (P < 0.05). The frequencies of intestinal parasites in the control group and the patient group were found to be 17.8% and 18.1%, respectively. From the findings it was concluded that presence of intestinal parasites and Microsporidium in cancer patients can cause critical problems and adversely affect the therapy. Moreover it was suggested that cancer patients should be informed about regular feces examination and protection against parasites in order to improve their life standards and protect them against parasite infections during treatment.en_US
dc.identifier.endpage112en_US
dc.identifier.issn1300-6320
dc.identifier.issue2en_US
dc.identifier.pmid18645938en_US
dc.identifier.scopus2-s2.0-60249090053en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage109en_US
dc.identifier.urihttps://hdl.handle.net/11616/91244
dc.identifier.volume32en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isotren_US
dc.relation.ispartofTürkiye parazitolojii dergisi / Türkiye Parazitoloji Derne?i = Acta parasitologica Turcica / Turkish Society for Parasitologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectadulten_US
dc.subjectanimalen_US
dc.subjectarticleen_US
dc.subjectBlastocystis hominisen_US
dc.subjectblastocystosisen_US
dc.subjectcase control studyen_US
dc.subjectfecesen_US
dc.subjecthumanen_US
dc.subjectintestine infectionen_US
dc.subjectisolation and purificationen_US
dc.subjectmicrobiologyen_US
dc.subjectMicrosporidaen_US
dc.subjectmycosisen_US
dc.subjectneoplasmen_US
dc.subjectparasitologyen_US
dc.subjectprevalenceen_US
dc.subjectAnimalsen_US
dc.subjectBlastocystis hominisen_US
dc.subjectBlastocystis Infectionsen_US
dc.subjectCase-Control Studiesen_US
dc.subjectFecesen_US
dc.subjectHumansen_US
dc.subjectIntestinal Diseases, Parasiticen_US
dc.subjectMicrosporidia, Unclassifieden_US
dc.subjectMycosesen_US
dc.subjectNeoplasmsen_US
dc.subjectPrevalenceen_US
dc.subjectYoung Adulten_US
dc.titleThe prevalence of Microsporidium among patients given a diagnosis of canceren_US
dc.title.alternativeKanser Tanisi Almiş Hastalarda Microsporidium Görülme Sikli?i.en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu